FDCDDQ
SNDX icon

Federation des caisses Desjardins du Quebec’s Syndax Pharmaceuticals SNDX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-250
Closed -$2.74K – 2253
2020
Q1 		$2.74K Hold
250
– – ﹤0.01% 1948
2019
Q4 		$2.19K Hold
250
– – ﹤0.01% 2130
2019
Q3 		$1.87K Hold
250
– – ﹤0.01% 2094
2019
Q2 		$2.33K Hold
250
– – ﹤0.01% 2092
2019
Q1 		$1.31K Hold
250
– – ﹤0.01% 1953
2018
Q4 		$1.11K Hold
250
– – ﹤0.01% 1953
2018
Q3 		$2.02K Hold
250
– – ﹤0.01% 1994
2018
Q2 		$1.75K Hold
250
– – ﹤0.01% 2030
2018
Q1 		$3.56K Hold
250
– – ﹤0.01% 1930
2017
Q4 		$2.19K Buy
+250
New +$2.47K ﹤0.01% 1987

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's SNDX Position: Q2 2020 in Review

Federation des caisses Desjardins du Quebec sold out of Syndax Pharmaceuticals (SNDX) in Q2 2020, closing a stake of 250 shares — an estimated $2.74K sold.

Federation des caisses Desjardins du Quebec first reported a position in SNDX in Q4 2017 and held it in 10 quarters. The position peaked at $3.56K in Q1 2018. 97 funds tracked by Wall St. Rank hold SNDX as of Q2 2020.

  • Federation des caisses Desjardins du Quebec reported no remaining Syndax Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 250 Syndax Pharmaceuticals shares in Q2 2020, an estimated $2.74K.
  • Federation des caisses Desjardins du Quebec first reported a position in Syndax Pharmaceuticals in Q4 2017 and held it in 10 quarters.
  • Federation des caisses Desjardins du Quebec's Syndax Pharmaceuticals position peaked at $3.56K in Q1 2018.
  • 97 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2020.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2020, filed 30 Aug 2024.